Minoxidil 2% for Eyebrow Enhancement
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01672307 |
Recruitment Status
:
Completed
First Posted
: August 24, 2012
Last Update Posted
: June 19, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hypotrichosis of Eyebrows Thinning Eyebrows | Drug: Minoxidil lotion 2% Drug: Placebo | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Efficacy and Tolerability of Minoxidil 2% for Eyebrow Enhancement : A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | November 2012 |
Actual Study Completion Date : | March 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Minoxidil lotion 2%
Minoxidil lotion 2% is applied twice daily to one eyebrow.
|
Drug: Minoxidil lotion 2%
Minoxidil lotion 2% is applied twice daily to one eyebrow.
|
Placebo Comparator: Placebo
Placebo is applied twice daily to the other eyebrow.
|
Drug: Placebo
Placebo is applied twice daily to the other eyebrow.
|
- The change of global photographic assessment after 16 weeks from baseline [ Time Frame: baseline and 16 weeks ]
- The change of hair diameter after 16 weeks from baseline [ Time Frame: baseline and 16 weeks ]
- The change in number of hairs after 16 weeks from baseline [ Time Frame: baseline and 16 weeks ]
- Number of participants with adverse events. Adverse events include any skin rashes or symptoms. [ Time Frame: 16 weeks ]
- Patient satisfaction by self-assessment questionnaires [ Time Frame: 16 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- male or female aged 18-40 years
- hypotrichosis of eyebrows
- healthy
- informed consent obtained
Exclusion Criteria:
- no underlying diseases
- no alopecia areata or trichotillomania
- no thyroid diseases
- no pregnancy or breast feeding
- no previous eyebrow tattoo, trauma or accident.
- no history of eyebrow or hair medications in 6 months
- no history of minoxidil or its ingredient allergy
- no history of eyebrow surgery.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01672307
Thailand | |
MFL University Hospital (Bangkok) | |
Bangkok, Thailand, 10110 |
Principal Investigator: | Chuchai Tanglertsampan, MD | MFL University Hospital (Bangkok) |
Responsible Party: | Chuchai TANGLERTSAMPAN, MD, Instructor, Mae Fah Luang University Hospital |
ClinicalTrials.gov Identifier: | NCT01672307 History of Changes |
Other Study ID Numbers: |
MFL University |
First Posted: | August 24, 2012 Key Record Dates |
Last Update Posted: | June 19, 2013 |
Last Verified: | June 2013 |
Keywords provided by Chuchai TANGLERTSAMPAN, MD, Mae Fah Luang University Hospital:
hypotrichosis of eyebrows thinning eyebrows minoxidil placebo randomized |
Additional relevant MeSH terms:
Hypotrichosis Hair Diseases Skin Diseases |
Minoxidil Antihypertensive Agents Vasodilator Agents |